Web-Based Cognitive Behavioral Therapy Blended With Videoconference Face-to-Face Sessions for Major Depression: A feasibility study

UMIN ID: UMIN000036911

Registered date:31/05/2019

Basic Information

• Recruitment status: Complete: follow-up complete
• Health condition(s) or Problem(s) studied: Major Depression
• Date of first enrollment: 2019/06/13
• Target sample size: 8
• Countries of recruitment: Japan
• Study type: Interventional
• Intervention(s): Web-Based Cognitive Behavioral Therapy Blended With Videoconference Sessions for Major Depression

Outcome(s)

• Primary Outcome: 1. Baseline reduction score of GRID-Hamilton Depression Rating Scale (GRID-HAMD) at 12wk 2. Drop-out rate
• Secondary Outcome: 1. Baseline reduction score of GRID-Hamilton Depression Rating Scale (GRID-HAMD) at 24 and 36wk 2. Beck Depression Inventory (BDI-II), Generalized Anxiety Disorder (GAD-7), Ruminative Responses Scale (RRS), Sheehan Disability Scale (SDISS), Cognitive-Behavioral Avoidance Scale (CBAS), Coping Inventory for Stressful Situations (CISS): 0,6,12,24,36 wks 3. Quick Inventory of Depressive Symptomatology (QIDS), Euro-Qol (EQ-5D), Session Rating Scale (SRS) at each session 4. Client satisfaction questionnaire (CSQ-8j): 0, 6,12 wks

Key inclusion & exclusion criteria

• Age minimum: 20years-old
• Age maximum: 70years-old
• Gender: Male and Female
• Exclude criteria: 1) No alcohol or substance use disorder in 12 months prior to the screening 2) No history or concurrent manic or psychotic episode 3) No other primary DSM-IV Axis I Disorders at screening 4) No comorbid of antisocial personality disorder 5) No serious suicidal ideation at screening 6) No organic brain lesions or major cognitive deficits in a year prior to the screening 7) No severe or unstable medical co-morbidities at screening 8) No past treatment of individual CBT sessions more than 8 9) No structured psychotherapy during the intervention 10) Other relevant reason decided by the CBT principal investigator

Related Information

• Primary Sponsor: Keio University School of Medicine, Department of Neuropsychiatry
• Source(s) of Monetary Support: National Center of Neurology and Psychiatry